Evidence That Raltegravir (Isentress, Merck), a Retroviral Integrase Inhibitor Is Effective Against Recurrent Human Herpes Simplex Virus Infection Associated With NK-cell Deficiency

Pediatrics & Therapeutics
doi 10.4172/2161-0665.1000172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Early Onset of Autoimmune Disease by the Retroviral Integrase Inhibitor Raltegravir

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Congenital Herpes Simplex Virus Infection

2020English

Herpes Simplex Virus Glycoproteins as Treatment for Recurrent Genital Herpetic Infection

Pediatric Research
Child HealthPediatricsPerinatology
1987English

Evidence That Two Latency-Associated Transcripts of Herpes Simplex Virus Type 1 Are Nonlinear.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

Topical Tenofovir, a Microbicide Effective Against HIV, Inhibits Herpes Simplex Virus-2 Replication

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2011English

Protective Antibody Therapy Is Associated With Reduced Chemokine Transcripts in Herpes Simplex Virus Type 1 Corneal Infection.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

Recurrent Herpes Simplex Type 2 Virus (Mollaret) Meningitis

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2004English

Ribonucleotide Reductase of Herpes Simplex Virus Type 2 Resembles That of Herpes Simplex Virus Type 1.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1984English

Mutations Associated With Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy